Breast Imaging Technologies Market worth $3 Billion by 2019, According to a New Study on ASDReports

Friday 29 August 2014, Amsterdam

The report, now available on ASDReports, “Breast Imaging Technologies Market (Analog Mammography, Digital Mammography, Tomosynthesis, Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound, Optical Imaging, Whole Breast Ultrasound, Breast Thermography) - Global Forecasts to 2019” analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).

This report studies the global breast imaging technologies market over the forecast period from 2014 to 2019. The market is expected to reach ~$3 billion by 2019, at CAGR of 8.1% from 2014 to 2019.

The global breast imaging technologies market is classified into two major segments, namely, ionizing breast imaging technologies and non-ionizing breast imaging technologies. The ionizing technologies segment is further categorized into analog mammography, full-field digital mammography, 3D breast tomosynthesis, positron emission tomography/computed tomography (PET/CT), molecular breast imaging (MBI), cone beam computed tomography (CBCT), and positron emission mammography (PEM). Likewise, non-ionizing technology market comprises breast MRI, breast ultrasound, optical imaging, whole breast ultrasound, and breast thermography.

A number of factors such as growing public and private initiatives to increase awareness about early breast cancer screening, rising incidences of breast cancer, increasing demand for use of minimal or negligible doses of radiation, and rapid growth in aging population are driving the growth of the global breast imaging technologies market. On the other hand, factors such as side effects of exposure of radiations received during application of ionizing breast imaging technologies and high investment and installation costs are restricting the growth of the this market. However, increasing government investments in novel breast imaging technologies and emerging economies including India and China offer new growth opportunities for the market players.

As of 2014, North America is estimated to hold the largest share of the global breast imaging technologies market, followed by Europe. However, the Asia-Pacific market is expected to grow at highest CAGR of 10.2% from 2014 to 2019. A number of factors including rising incidences of breast cancer, increasing focus on early screening of breast cancer, and development of healthcare infrastructure are stimulating the growth of the breast imaging technologies market in the Asia-Pacific region.

Aurora Imaging Technology, Inc. (U.S.), Dilon Technologies, Inc. (U.S.), Dune Medical Devices (U.S.), Gamma Medica, Inc. (U.S.), GE Healthcare (U.K.), Hologic, Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), Siemens AG (Germany), SonoCine, Inc. (U.S.), and Toshiba Corporation (Japan) are the major players in the global breast imaging technologies market.